-
New Process Discovered for Fighting Contact Lens Bacteria
Researchers at National Jewish Health in Denver, Colorado and the University of Texas Southwestern Medical Center in Dallas, Texas have discovered a new method to fight bacterial infections from contact lenses. The results were published online January 18 in the journal Investigative Ophthalmology and Visual Science (paid subscription required). The problem arises from the interference…
-
Researchers Improve Efficiency of LED Lighting
Researchers from North Carolina State University in Raleigh have developed a new technique that reduces defects in the gallium nitride (GaN) films used to create light-emitting diodes or LEDs, making this energy-efficient form of lighting even more efficient. The team of engineers and and materials scientists published their findings online in the 17 January issue…
-
Grant Awarded to Company for Kennedy’s Disease Research
AndroScience Corp., a drug discovery and development company in San Diego, California, said it received a $3.8 million translational research grant to help develop a treatment for spinal and bulbar muscular atrophy, also called Kennedy’s Disease. The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health awarded the grant. The…
-
Orphan Drug Status Granted for Melanoma Vaccine
BioSante Pharmaceuticals Inc. said today it received from the U.S. Food and Drug Administration orphan drug designation for its melanoma cancer vaccine to treat stage IIb to IV melanoma. BioSante Pharmaceuticals is a specialty pharmaceutical company in Lincolnshire, Illinois. Orphan drug designation, as granted by the Orphan Drug Act, is for a product to treat…
-
Heart Disease Treatment Cost Expected to Triple by 2030
An economic forecast by an American Heart Association (AHA) panel indicates that the cost to treat heart disease in the United States is expected to triple to $818 billion by 2030 from $273 billion in 2010. The findings are contained in a policy statement published in the online issue of Circulation: Journal of the American…
-
Engineers Develop Wireless Spectrum-Sensing Algorithms
Researchers at Virginia Tech in Blacksburg have developed a set of mathematical rules to help build more reliable and efficient spectrum-sensing techniques needed to meet the expanding demand for wireless technologies. This first phase of a more than two-year study is funded by wireless technology developer InterDigital of King of Prussia, Pennsylvania. Spectrum-sensing technologies are…
-
Research Spin Off Company to Tackle Superbug Infections
Fixed Phage Limited in Glascow, Scotland has been launched to commercialize a technology for tackling bacterial infection and contamination, including superbugs such as MRSA. That technology was developed at the University of Strathclyde Institute of Pharmacy and Biomedical Sciences in Scotland. Fixed Phage’s technology is based on research for treatment and prevention of infection and…
-
Device Maker, Heart Institute Fund Cardiac Device Study
The National Heart, Lung and Blood Institute (NHLBI) and HeartWare, a developer of left ventricular assist devices in Framingham, Massachusetts, have awarded $13.3 million to two universities explore the potential of heart devices for people with heart failure. NHLBI is part of the U.S. National Institutes of Health. The University of Michigan Cardiovascular Center and…
-
Cleantech, Electronics Venture Funding Jump in 2010
Venture capital investments recorded a solid increase in 2010 over 2009, the first annual jump since 2007. Industries based on science and engineering were among the gainers, particularly clean technology and electronics. The statistics were contained in the MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters.…
-
Finance Friday: 21 January 2011
Here are recent angel and venture finance transactions for science- and engineering-based companies reported by CB Insights … Biomedical/Life sciences Fluidigm in South San Francisco, California. Medical devices and equipment. $5 million, debt Cognition Therapeutics in Pittsburgh, Pennsylvania. Discovery and development of small molecule therapeutics. $2.5 million, series A equity Adhezion Biomedica in Wyomissing, Pennsylvania.…